Private Capital Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$24K Sell
181
-96
-35% -$13.1K 0.02% 767
2022
Q1
$38K Sell
277
-88
-24% -$12.3K 0.01% 747
2021
Q4
$63K Hold
365
0.01% 587
2021
Q3
$53K Hold
365
0.01% 642
2021
Q2
$48K Sell
365
-2
-0.5% -$262 0.01% 699
2021
Q1
$47K Sell
367
-26
-7% -$3.2K 0.01% 676
2020
Q4
$47K Sell
393
-49
-11% -$5.97K 0.01% 822
2020
Q3
$51K Sell
442
-102
-19% -$12.1K 0.01% 697
2020
Q2
$62K Sell
544
-26
-5% -$2.76K 0.01% 612
2020
Q1
$46K Buy
570
+173
+44% +$17.9K 0.01% 676
2019
Q4
$42K Sell
397
-91
-19% -$9.49K 0.01% 815
2019
Q3
$52K Buy
488
+225
+86% +$23.1K 0.01% 755
2019
Q2
$29K Sell
263
-225
-46% -$21.6K 0.01% 908
2019
Q1
$44K Buy
488
+10
+2% +$867 0.01% 837
2018
Q4
$40K Hold
478
0.01% 772
2018
Q3
$51K Buy
478
+115
+32% +$12.6K 0.01% 706
2018
Q2
$39K Sell
363
-2
-0.5% -$208 0.01% 805
2018
Q1
$37K Buy
365
+243
+199% +$24.9K 0.01% 816
2017
Q4
$116K Buy
+122
New +$11.6K 0.03% 359

Other funds holding DGX

Private Capital Group's DGX Position: Q2 2022 in Review

Private Capital Group reduced its Quest Diagnostics (DGX) stake by 35% in Q2 2022, selling an estimated $13.1K and leaving 181 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #767.

Private Capital Group first reported a position in DGX in Q4 2017 and has held it in 19 quarters since. The position peaked at $116K in Q4 2017. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Private Capital Group held 181 shares of Quest Diagnostics worth $24K as of Q2 2022.
  • Private Capital Group sold 96 Quest Diagnostics shares in Q2 2022, an estimated $13.1K.
  • Quest Diagnostics made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #767 holding.
  • Private Capital Group first reported a position in Quest Diagnostics in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Quest Diagnostics position peaked at $116K in Q4 2017.
  • 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.